Member Info for VikR

‘Fusion Antibodies is delighted to be attending this year’s Antibody Engineering and Therapeutics conference in San Diego from 4 – 8 December 2022’

Join Chris Winch commercial director and Chief Scientific Officer Richard Buick as he delivers an exciting briefing on Fusion Antibodies’ leading R&D programme: OptiMAL® – A Novel Library and Mammalian Display Platform for Antibody Discovery (Tuesday December 6th at 12:05pm).

To the current day

14-17th Dec 2025

And today is the start of the world renowned San Diego conference and platform for the official commercial launch of Optimal. BOD and key players in attendance and a stamp of approval from senior organiser of the event Dr Mitchell Ho.

It does not get any better then this astute investors

Hey resident deramper STI I was awaiting your miserable contribution. The entire year you have arrived periodically and been -

6p - bearish

8-p bearish

13p - bearish

19p - bearish

You have been negative every step of the journey and wrong all the way. Surely even now you must realise the error of your ways.

I’m sure you will be here at

35p

44p

84p

£1.05

I’m sure you can see the pattern

Now that we have breached 20 million market cap the funds that we attract open up significantly as many institutional investors have a 20 million market cap minimum threshold for placing funds.

Sorry meant *The Friday just gone

Narrow window to get in for those not loaded and holding already. The most I managed on Monday was a few £k was very hard to acquire any, demand must be huge

He has been very bullish on the charts for some time with a first pit stop to 8.80p, rightly so as some shares are a lot more evidenced based and less speculative with GSCU being the former. Whenever I have spare funds they go into this share as over the medium term it’s going to be nowhere near single figures in the future.

One of the best buys going into 2026 and extremely confident with this one

On that note fair journey also have a stand at the San Diego conference but as the recently published literature shows Optimal obliterates and trumps alternative antibody methods by some margin (think 70%transduction efficiency). I would hypothesize that Pedro may be who fair journey approach to make some informal bids off the table and gauge selling interest. None of the BOD are getting any younger and I don’t think they would rule out serious offers that attribute true value to the entire portfolio in situ.

Whatever happens from this moment going forward none of us can lose out whether that be total buy out or lots of contracts with some massive milestone royalties attached. This really is a de risked model and subsequently a de risked buy for even the most risk averse investor. I must say though competitor scientists will be racking brains day and night to better optimal but that’s a problem for another day. Whilst we are patent protected I’m happy with the near term security and exclusivity of 5-10 years optimal can offer.

Brought in 2 weeks ago but must admit I haven’t started loading heavy yet. Given the historical circumstances seems to have disgruntled a lot of investors however given what I am seeing of the CEOs proactive efforts on LinkedIn makes me err towards a bullish stance. Hopefully his own £0.25 million investment adds some form of credibility. As and when I start topping up be sure to keep the community informed

Good luck

Very reassuring to see multiple projections and interests from other influential investors. Good baseline built up here for me over last week with a view to holding well into 2026.

Lucky find for me this share, as re iterated previously this and JAN will hopefully the making of my investment portfolio

Good luck ALTHs and any newbie investors like me

A great week for all investors and this was always in the making. Unfortunately last time we had reached 21p optimal wasn’t quite ready so we ended up drifting down. The landscape has now completely changed and pretty soon we will never see below 20p again.

It has been an exhilarating, exhausting but rewarding journey thus far and we haven’t even truly begun the real re rate yet

Have a blessed, safe and fun weekend all

Does bode well for setting the scene next week.

Have a good week all vested investors and remain prosperous, safe and healthy

Can’t see my £13k buy on the books yet, MMs will probably report it after hours to disguise the buy

Not here for the short ups and downs as mentioned the news could land in one hour or one week. I’m patient enough to wait given the favorable likely outcome of success. That’s what makes an astute investor

Yes just checked the corrupt market makers have posted it as a sell. Thats exactly why I always post any significant buys ( well for me anyway) and quantify them to ensure everyone has accurate information and not to rely on what the MMs post to disguise and confuse the investment community.

Definite load and hold for me for the imminent game changing RNS. Over 0.1 billion shares in situ now

Did a few £500 transactions

And some £1000 transactions

This will have to make do for now. Glad I got my baseline £ 20k in last week

Couldn’t resist a top up

755380 shares for 1.72p @ 13:46 for £13000

Load and hold

Astute investors

I’m trying to load heavy here and it won’t let me top up.

Just put in £1k and then tried to repeat no quote, trying to pump serious money in

No brainer to continue topping up at these levels transacted at 13:37

Yes

Please do keep sharing I am not a long term investor here but only joined within the last 2 weeks. Whilst I am not fully clued on to the opportunity as much as others the learning points from more embedded investors is invaluable. From what I have seen as an investment though looks solid enough for me to have acquired a few million shares with a view to slowly adding more

Load and hold is the best analogy for this share right now

Yes exactly that,

A charting trainer I use, who is independent and unbiased also interpreted the chart for me and came to the same conclusion. I am glad you mentioned that as it reinforces my sentiment even further when technicals are in full alignment and verified by multiple unrelated sources.